Hong Kong Drug Regulators To Step Up Inspections To Improve Drug Safety
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Hong Kong regulators may step up inspections of drug manufacturing facilities outside the former British enclave following a series of recommendations in December to improve drug safety